Malignant pleural mesothelioma (MPM) is an aggressive cancer with rising incidence and
challenging clinical management. Through a large series of whole-genome sequencing data, …

Background Self-expanding metallic stents (SEMSs) have been used as a bridge to surgery,
relieving dysphagia and maintaining nutrition, in patients with operable but obstructive …

In the last few years, the treatment of patients with non-small cell lung cancer (NSCLC) has
impressively benefitted from immunotherapy, in particular from the inhibition of immune …

Aims The aims of this study were to compare short- and long-term outcomes for clinical T2N0
oesophageal cancer with analysis of (i) primary surgery (S) versus neoadjuvant therapy …

Objectives The effect of anti-PD-1/PD-L1 inhibitors on lung adenocarcinomas (LADCs) with
KRAS mutations is debatable. We examined the association between specific mutant KRAS …

Abstract Treatment with EGFR inhibitors is limited to patients with advanced/metastatic non-small
cell lung cancer who have known EGFR mutations. Currently, patient care has to …

Background Locoregional recurrence rates after definitive chemoradiotherapy (dCRT) for
locally advanced esophageal cancer (EC) are high. Salvage surgery (SALV) is considered the …

Introduction Lung cancer (LC) is the leading cause of death from cancer. Early diagnosis of
LC is of paramount importance in terms of prognosis. The health authorities of most countries …

Introduction Both MET expression and the PD-L1 tumor proportion score (TPS) are companion
diagnostics for treatment of advanced non-small cell lung carcinoma (aNSCLC) patients. …

There is a rising trend in high risk sexual behaviour among men who have sex with men (MSM),
with concomitant use of recreational drugs. Activities include fisting and unprotected …